These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroleptic malignant syndrome during a change from haloperidol to risperidone. Reeves RR, Mack JE, Torres RA. Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988 [Abstract] [Full Text] [Related]
5. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy. Ghaffari N, Dossett E, Lee RH, Aghajanian P. Obstet Gynecol; 2012 Feb; 119(2 Pt 2):436-438. PubMed ID: 22270430 [Abstract] [Full Text] [Related]
18. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents. Zalsman G, Lewis R, Konas S, Loebstein O, Goldberg P, Burguillo F, Nahshoni E, Munitz H. Int J Adolesc Med Health; 2004 Nov 07; 16(2):179-82. PubMed ID: 15266995 [Abstract] [Full Text] [Related]
19. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies. Sechi G, Agnetti V, Masuri R, Deiana GA, Pugliatti M, Paulus KS, Rosati G. Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug 07; 24(6):1043-51. PubMed ID: 11041543 [Abstract] [Full Text] [Related]